Home Tags Heinz Schwer

Tag: Heinz Schwer

Boehringer Ingelheim acquires ViraTherapeutics for $245 million

Austrian biopharmaceutical company ViraTherapeutics specializes in the development of oncolytic viral therapies to fight cancer.